Craig-Hallum Reiterates a Buy Rating on Cellebrite DI Ltd. (CLBT)

Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the best stocks under $20 to buy for the long term. On August 19, Craig-Hallum analyst Jeff Van Rhee maintained a Buy rating on Cellebrite DI Ltd. (NASDAQ:CLBT).

The rating update came after Cellebrite DI Ltd. (NASDAQ:CLBT) reported its fiscal Q2 2025 results on August 14 and announced the appointment of Thomas E. Hogan as CEO.

Cellebrite DI Ltd. (NASDAQ:CLBT) reported an 18% growth in revenue to $113.3 million, with ARR growing 21% to $418.9 million.

Net income for the quarter reached $19.5 million, supporting non-GAAP net income of $30.8 million and adjusted EBITDA of $27.9 million.

Cellebrite DI Ltd. (NASDAQ:CLBT) provides digital investigative solutions for the private and public sectors. The company’s services include value realization, training and advisory, technical customer support, and advanced services.

While we acknowledge the potential of CLBT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.